# HosPrime Loop Engineering 0197 — M0.3 Trial Readiness — BASELINE

Date: 2026-07-11
Controlling issue: #158
Parent issue: #157
Loop stage completed: BASELINE
Single next stage: RESEARCH

## North Star outcome supported

Protect Trusted Task Completion Rate, evidence quality, user trust, decision-to-outcome traceability and zero unauthorized high-impact action by measuring the exact gap between a defined M0.3 trial-governance model and an actually authorized, executable, real-user observation.

## Real user and real work problem

The future user is a consenting healthcare/public-health manager who must independently recover the synthetic meeting → decision → task/source → lesson chain in Obsidian.

The organizational work problem is that the repository now defines the required roles, authority boundaries, consent rules and handoffs, but has no completed evidence showing that any person, runtime, repository state or execution window is authorized for a trial. Without that distinction, a governance design artifact could be mistaken for trial readiness or a Trusted Task Completion Rate attempt.

## Repository control state inspected

At the start of this run:

- README North Star and Core Rules were present on `main`;
- the controlled release target remained Milestone 0 — Personal Twin OS v0.1;
- M0.3 remained `NEXT`, with usable backlinks and graph navigation as its acceptance signal;
- issue #158 remained open and controlling;
- recent relevant runs 0194, 0195 and 0196 preserved the ordered loop through NEXT GOAL → REAL PROBLEM → REAL USER;
- open pull requests found: 0;
- latest pre-run `main` commit: `7251df82c16934a17c5f0fce59ee152c80a22915`;
- combined status records on that commit: 0;
- no CI pass, runtime success or user acceptance is claimed.

## Baseline measurement method

Two layers were measured separately:

1. **Readiness-model coverage** — whether the repository defines the controls needed for a legitimate trial.
2. **Execution-readiness evidence** — whether those controls have actually been assigned, authorized and recorded for one bounded trial.

A model definition does not satisfy an execution-readiness gate.

## A. Readiness-model coverage baseline

Evidence source: engineering run 0196.

| Control | Required | Observed | Baseline result |
|---|---:|---:|---:|
| Accountable role classes defined | 5 | 5 | 5/5 PASS |
| Authority boundaries defined | 5 | 5 | 5/5 PASS |
| Ordered role handoffs defined | 10 | 10 | 10/10 PASS |
| Explicit, voluntary, withdrawable consent rules | 1 | 1 | PASS |
| Minimum separation-of-duties rules | 1 | 1 | PASS |
| Stop/defer conditions | 1 set | 1 set | PASS |
| Zero-unauthorized-action boundary | 1 set | 1 set | PASS |

Readiness-model coverage:

```text
MODEL_CONTROL_GROUPS_COMPLETE = 7/7
ROLE_CLASSES_DEFINED = 5/5
AUTHORITY_BOUNDARIES_DEFINED = 5/5
HANDOFFS_DEFINED = 10/10
MODEL_READY = true
```

This means the governance model is sufficiently specified for later research and authorization planning. It does not mean a trial is authorized.

## B. Execution-readiness evidence baseline

The eight evidence requirements defined in run 0195 were checked for completed, trial-specific records.

| Trial-specific evidence gate | Target | Current observed state | Score |
|---|---:|---|---:|
| Complete authorization receipt with validity window | 1 | absent | 0/1 |
| Authorized technical executor and permitted actions | 1 | absent | 0/1 |
| Explicit consenting manager participant record | 1 | absent | 0/1 |
| Delegated acceptance-authority record | 1 | absent | 0/1 |
| Recorded runtime environment and vault boundary | 1 | absent | 0/1 |
| Fixed repository SHA and unchanged fixture inventory | 1 | not authorized for execution | 0/1 |
| Trial-specific synthetic-data-only confirmation | 1 | general boundary exists; no signed trial confirmation | 0/1 |
| Planned audit/receipt location assigned for the trial | 1 | template exists; no trial package opened | 0/1 |

Execution-readiness coverage:

```text
EXECUTION_READINESS_GATES_COMPLETE = 0/8
EXECUTION_READINESS_RATE = 0%
AUTHORIZATION_RECEIPT_COMPLETE = false
TRIAL_READY = false
```

The controlled receipt template and repository evidence location are reusable infrastructure, but they do not count as a completed trial-specific receipt or an opened evidence package.

## Current outcome metrics

```text
CONTRACT_READY = true
MODEL_READY = true
TRIAL_READY = false
AUTHORIZED_RUNTIME_TRIALS = 0
AUTHORIZED_MANAGER_TRIALS = 0
APPROVED_TARGET_TASKS_ATTEMPTED = 0
ACCEPTED_TASKS_COMPLETED = 0
TRUSTED_TASK_COMPLETION_RATE = NOT_COMPUTABLE
MEDIAN_TIME_SAVED = NOT_COMPUTABLE
COST_PER_ACCEPTED_TASK = NOT_COMPUTABLE
REAL_USER_ACCEPTANCE_OBSERVED = false
UNAUTHORIZED_HIGH_IMPACT_ACTIONS = 0
M0_3_DONE = false
```

TTCR is not `0%`; it is not computable because no approved target task has been attempted.

## Measurable target for the next stages

Before any Obsidian execution, later stages must move execution-readiness evidence from `0/8` to `8/8` while preserving:

```text
UNAUTHORIZED_HIGH_IMPACT_ACTIONS = 0
REAL_CONFIDENTIAL_DATA_USED = 0
FIXTURE_MUTATIONS = 0
UNREVIEWED_MEMORY_PROMOTIONS = 0
```

Only after `8/8` readiness gates are complete may a later authorized trial establish the first TTCR denominator and task-duration baseline.

## Baseline interpretation

The dominant bottleneck is not role-model design, graph feature volume, agent count, screens or documentation volume.

```text
GOVERNANCE_MODEL_DEFICIT = resolved for current scope
TRIAL_SPECIFIC_EVIDENCE_DEFICIT = 8/8 gates missing
```

Therefore additional product or fixture work would not improve trial readiness. The next useful stage is bounded research into the minimum valid authorization, consent, delegation and evidence-retention content appropriate for this synthetic usability trial, using primary or official sources where material and retaining findings in Research Staging until review.

## Stop conditions

Do not execute or count a task attempt if any of the eight execution-readiness gates remains incomplete, consent is absent or withdrawn, the authorized SHA/environment changes, real confidential data appears, evidence capture fails, or technical operation is represented as user acceptance.

No participant was recruited or identified. No authorization was inferred from repository ownership or prior conversation. No Obsidian runtime, fixture mutation, RAG activation, memory promotion, publication or high-impact action occurred.

## Evidence and traceability

- North Star, milestone board, controlled release target and Core Rules: `README.md` on `main`.
- Selected next goal: `engineering_runs/2026-07-11/0194-m0-3-runtime-observation-gate-next-goal.md`.
- Real-problem evidence: `engineering_runs/2026-07-11/0195-m0-3-trial-readiness-real-problem.md`.
- Real-user evidence: `engineering_runs/2026-07-11/0196-m0-3-trial-readiness-real-user.md`.
- Controlled receipt contract: `docs/testing/M0_3_OBSIDIAN_RUNTIME_TRIAL_RECEIPT_TEMPLATE.yml`.
- Controlling issue: https://github.com/kongsak4807017/hosprime/issues/158
- Parent issue: https://github.com/kongsak4807017/hosprime/issues/157

## Test and CI status

No parser, product, Obsidian runtime or manager acceptance test was executed during BASELINE. Repository control state, recent relevant runs, issue state, open pull requests, latest commit and combined status records were inspected.

- open pull requests: 0;
- combined statuses on the pre-run latest commit: none;
- CI pass: not claimed;
- runtime execution: not performed;
- manager task: not performed;
- user acceptance: not observed.

## Memory layer affected

Engineering-run evidence and issue traceability only. Personal/Staff Twin Memory, Person Memory, Role Memory, Organizational Memory/Governed RAG and Research Staging were not modified or promoted. The synthetic fixture and controlled receipt template were unchanged.

## Risks and blockers

- All eight trial-specific execution-readiness evidence gates remain incomplete.
- No completed authorization receipt or validity window.
- No recorded authorized technical executor.
- No consenting manager participant.
- No delegated acceptance authority.
- No trial-specific runtime environment, fixed SHA or evidence package.
- Limited staffing may create separation-of-duties conflicts requiring an explicit compensating review control.

Accountable owner: repository/product owner or explicitly delegated M0.3 authorizer.

## Stage outcome

```text
BASELINE_STATED = true
MODEL_CONTROL_GROUPS_COMPLETE = 7/7
EXECUTION_READINESS_GATES_COMPLETE = 0/8
TRIAL_READY = false
AUTHORIZED_TRIAL_EXECUTED = false
UNAUTHORIZED_CLAIMS_ADDED = 0
MEMORY_PROMOTIONS = 0
M0_3_DONE = false
```

## Single next stage

RESEARCH — identify the minimum authoritative requirements and practical evidence fields for bounded authorization, participant consent, role delegation, separation-of-duties exceptions and evidence retention for the synthetic M0.3 trial. Keep all external findings in Research Staging until reviewed.